期刊文献+

N-乙酰半胱氨酸改善高脂高糖联合缺氧/复氧致H9C2心肌细胞损伤的实验研究

Experimental study on the effect of N-acetylcysteine on H9C2 cardiomyocyte injury induced by high-fat and high-glucose combined with hypoxia/reoxygenation
下载PDF
导出
摘要 目的探讨抗氧化剂N-乙酰半胱氨酸(NAC)对高脂高糖联合缺氧/复氧所致H9C2心肌细胞损伤及其对时钟基因BMAL1表达的影响。方法将培养的H9C2细胞分为对照组(N组)、高脂高糖联合缺氧/复氧组(HFHG+H/R组)、高脂高糖联合缺氧/复氧+NAC组(HFHG+H/R+NAC组)。CCK-8法检测细胞活性,流式细胞术检测细胞凋亡,DCFH-DA染色观察活性氧(ROS)水平,JC-1染色检测细胞线粒体膜电位(MMP),Western blot测定BMAL1表达水平。结果与N组比较,HFHG+H/R组细胞活性明显降低(P <0.01),凋亡率与ROS水平明显升高(P <0.01),而BMAL1表达水平显著降低(P <0.01)。经NAC处理后,HFHG+H/R+NAC组以上变化均显著减小,差异有高度统计学意义(P <0.01)。HFHG+H/R组MMP较N组明显降低;经NAC处理后,HFHG+H/R+NAC组MMP明显升高。结论 NAC可能通过抑制心肌细胞氧化应激水平,并促进时钟基因BMAL1表达,从而减小高脂高糖与缺氧/复氧所导致的心肌细胞损伤。 Objective To investigate the effect of antioxidant N-acetylcysteine (NAC) on H9C2 cardiomyocyte injury induced by high-fat and high-glucose combined with hypoxia/reoxygenation and its effect on the expression of clock gene BMAL1. Methods H9C2 cells were divided into control group (N group), high-fat and high-glucose combined with hypoxia/reoxygenation group (HFHG+H/R group), high-fat and high-glucose combined with hypoxia/reoxygenation +NAC group (HFHG+H/R+NAC group). Cell viability was detected by CCK-8 method, cell apoptosis was detected by the flow cytometry, reactive oxygen species (ROS) level was observed by DCFH-DA staining, mitochondrial membrane potential (MMP) was detected by JC-1 staining, and the expression level of BMAL1 was determined by Western blot. Results Compared with N group, the cell viability of HFHG+H/R group was significantly lower (P < 0.01), the apoptosis rate and ROS level were significantly increased (P < 0.01), while the expression level of BMAL1 was significantly reduced (P < 0.01). After NAC treatment, the changes of indicators above in the HFHG+H/R+NAC group were significantly reduced, the differences were highly statistically significant (P < 0.01). MMP in the HFHG+H/R group was significantly lower than that in the N group. After NAC treatment, MMP of HFHG+H/R+NAC group was significantly increased. Conclusion NAC may reduce the oxidative stress level of cardiomyocytes and promote the expression level of clock gene BMAL1, thereby reducing cardiomyocyte damage induced by high-fat and high-glucose combined with hypoxia/reoxygenation.
作者 李源 夏中元 LI Yuan;XIA Zhongyuan(Department of Anesthesiology, Renmin Hospital of Wuhan University, Hubei Province, Wuhan 430060, China)
出处 《中国医药导报》 CAS 2019年第6期4-7,I0003,共5页 China Medical Herald
基金 国家自然科学基金资助项目(81671891)
关键词 N-乙酰半胱氨酸 BMAL1 氧化应激 心肌细胞 N-acetylcysteine BMAL1 Oxidative stress Cardiomyocyte
  • 相关文献

参考文献3

二级参考文献42

  • 1Ting-Jun FAN,Li-Hui HAN,Ri-Shan CONG,Jin LIANG.Caspase Family Proteases and Apoptosis[J].Acta Biochimica et Biophysica Sinica,2005,37(11):719-727. 被引量:100
  • 2Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidityand mortality in diabetics in the Framingham population. Sixteenyear follow-up study. Diabetes 1974; 23: 105-111 [PMID: 4359625DOI: 10.2337/diab.23.2.105].
  • 3Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, BelangerAJ, Wolf PA. Independent risk factors for atrial fibrillation in apopulation-based cohort. The Framingham Heart Study. JAMA1994; 271: 840-844 [PMID: 8114238 DOI: 10.1001/jama.1994.03510350050036].
  • 4Huxley RR, Filion KB, Konety S, Alonso A. Meta-analysis ofcohort and case-control studies of type 2 diabetes mellitus andrisk of atrial fibrillation. Am J Cardiol 2011; 108: 56-62 [PMID:21529739].
  • 5Stahn A, Pistrosch F, Ganz X, Teige M, Koehler C, BornsteinS, Hanefeld M. Relationship between hypoglycemic episodesand ventricular arrhythmias in patients with type 2 diabetesand cardiovascular diseases: silent hypoglycemias and silentarrhythmias. Diabetes Care 2014; 37: 516-520 [PMID: 24041680DOI: 10.2337/dc13-0600].
  • 6Pistrosch F, Ganz X, Bornstein SR, Birkenfeld AL, HenkelE, Hanefeld M. Risk of and risk factors for hypoglycemia andassociated arrhythmias in patients with type 2 diabetes andcardiovascular disease: a cohort study under real-world conditions.Acta Diabetol 2015; 52: 889-895 [PMID: 25749806 DOI: 10.1007/s00592-015-0727-y].
  • 7Ball J, Carrington MJ, McMurray JJ, Stewart S. Atrial fibrillation:profile and burden of an evolving epidemic in the 21st century. IntJ Cardiol 2013; 167: 1807-1824 [PMID: 23380698 DOI: 10.1016/j.ijcard.2012.12.093].
  • 8Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitusis a strong, independent risk for atrial fibrillation and flutter inaddition to other cardiovascular disease. Int J Cardiol 2005; 105:315-318 [PMID: 16274775].
  • 9Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinicalrelevance in atrial fibrillation. J Am Coll Cardiol 2008; 51: 802-809[PMID: 18294563 DOI: 10.1016/j.jacc.2007.09.064].
  • 10Corradi D. Atrial fibrillation from the pathologist's perspective.Cardiovasc Pathol 2006; 23: 71-84 [PMID: 24462196 DOI:10.1016/j.carpath.2013.12.001].

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部